INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Institution
LT

Lantheus Alpha Therapy, LLC

10% OwnerCIK 0002010224

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score35
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$251K
80.8K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Perspective Therapeutics, Inc.10% Owner · Sep 4, 2026
28
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL
$526K
167.1K sh
Sep 4, 2026
Sep 8, 2026
traded Sep 4, 2026
+4d
SEC FORM 4

Evidence

25
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$131K
42.1K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC FORM 4

Evidence

35
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$246K
78.1K sh
Aug 31, 2026Sep 4, 2026
traded Aug 31, 2026
+4dSEC FORM 4

Evidence

31
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$112K
35.8K sh
Sep 1, 2026Sep 4, 2026
traded Sep 1, 2026
+3dSEC FORM 4

Evidence